The net result was a significant increase in TRAIL-mediated killing of B-CLL cells, such that over 30% of B-CLL cells became Annexin-V+ during the 4 hours TRAIL incubation period. Here, TNFSF10 is linked to B-cell chronic lymphocytic leukemia.